Results 61 to 70 of about 5,567 (162)

Endometrial microbiota‐targeted therapies for chronic endometritis‐associated recurrent implantation failure and their impact on IVF outcomes: A systematic review and methodological quality assessment

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 3, Page 418-435, March 2026.
Microbiota‐targeted interventions may improve implantation and pregnancy outcomes in women with chronic endometritis‐associated recurrent implantation failure. However, current evidence is constrained by heterogeneous study designs, nonstandardized diagnostic criteria, small cohort sizes, and limited adjustment for confounding factors.
Bogdan Doroftei, Ovidiu‐Dumitru Ilie, Ana‐Maria Dabuleanu (Cretu), Iulia Selaru, Gabriela Lunguleac, Mara Doroftei, Ciprian Ilea   +6 more
wiley   +1 more source

The human mycobiome in health and disease [PDF]

Genome Medicine, 2013
The mycobiome, referring primarily to the fungal biota in an environment, is an important component of the human microbiome. Despite its importance, it has remained understudied. New culture-independent approaches to determine microbial diversity, such as next-generation sequencing methods, are greatly broadening our view of fungal importance.
Cui, L, Morris, A, Ghedin, E
openaire   +2 more sources

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications

Molecular Cancer
The polymorphic microbiome is considered a new hallmark of cancer. Advances in High-Throughput Sequencing have fostered rapid developments in microbiome research. The interaction between cancer cells, immune cells, and microbiota is defined as the immuno-
Ting Ding, Chang Liu, Zhengyu Li
doaj   +1 more source

Alterations of the gut mycobiome in patients with MS

EBioMedicine, 2021
Background: The mycobiome is the fungal component of the gut microbiome and is implicated in several autoimmune diseases. However, its role in MS has not been studied.
Saumya Shah, Alberto Locca, Yair Dorsett, Claudia Cantoni, Laura Ghezzi, Qingqi Lin, Suresh Bokoliya, Hunter Panier, Cassandra Suther, Matthew Gormley, Yue Liu, Emily Evans, Robert Mikesell, Kathleen Obert, Amber Salter, Anne H Cross, Phillip I. Tarr, Amy Lovett-Racke, Laura Piccio, Yanjiao Zhou   +19 more
doaj   +1 more source

Biogeography and host associations of Russula subsection Xerampelinae based on large‐scale analysis of UNITE sequence data

New Phytologist, Volume 249, Issue 5, Page 2547-2558, March 2026.
Summary Estimating fungal geographic ranges and niche potential is limited by the ephemeral nature of fruiting bodies. While environmental DNA offers broader insights, species‐level identification remains difficult due to uncertain sequence clustering thresholds, low interspecific variation in barcoding regions, and limited taxonomic resolution.
Chance R. Noffsinger, Miroslav Caboň, P. Brandon Matheny, Katarína Adamčíková, Brian P. Looney, Urmas Kõljalg, Kessy Abarenkov, Slavomír Adamčík   +7 more
wiley   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Gut Microbiome Dysbiosis is Associated With Human T‐Lymphotropic Virus Type 1 (HTLV‐1) Infection and Disease Progression to HTLV‐1‐Associated Myelopathy/Tropical Spastic Paraparesis: A Cross‐Sectional Study

Smart Medicine, Volume 5, Issue 1, February 2026.
We provide the first comprehensive analysis of changes in the gut bacteriome at different clinical stages of HTLV‐1 infection. HTLV‐1 infection is associated with a dysbiosis that includes reduced bacterial diversity and an inverted Firmicutes/Bacteroidetes ratio.
Lorena Abreu Fernandes, Ana Olivia de Souza, Youko Nukui, Rosa Maria Marcusso, Augusto César Penalva de Oliveira, Jorge Casseb, Patricia Bianca Clissa, Silas G. Villas‐Boas, Sabri Saeed Sanabani   +8 more
wiley   +1 more source

Human Gut Mycobiome in IBD [PDF]

, 2020
The human microbiota is a diverse microbial ecosystem associated with many beneficial physiological functions, as well as numerous disease etiologies. Dominated by bacteria, the microbiota also includes commensal populations of fungi, viruses, archaea, and protists.
Mario Matijasic, Tomislav Meštrović, Hana Čipčić Paljetak, Mihaela Perić, Anja Barešić, Donatella Verbanac   +5 more
openaire   +1 more source

Gut Fungal Microbiota Alterations in Pulmonary Arterial Hypertensive Rats

Biomedicines
The gut microbiome’s imbalance has been implicated in the pathogenesis of pulmonary arterial hypertension (PAH), yet the contribution of the gut mycobiome remains largely unclear.
Yihang Chen, Liukun Meng, Wen Yuan, Zehan Gao, Xun Zhang, Boqia Xie, Jiawei Song, Jifeng Li, Jiuchang Zhong, Xiaoyan Liu   +9 more
doaj   +1 more source

Bacterial Communities as Modulators of Innate Immune Signalling: An In Vitro Perspective on Toll‐Like Receptor Activation

Environmental Microbiology Reports, Volume 18, Issue 1, February 2026.
Bacterial contaminants in occupational environments may elicit an immune response. This study investigated the immune‐modulatory potential of bacterial communities using in vitro cell‐based assays and revealed distinctive bacterial species as drivers of TLR2 and TLR4 activation. The presented approach studied the role of bacterial species as modulators
Elke Eriksen, Pål Graff, Anani Komlavi Afanou   +2 more
wiley   +1 more source